Rosuvastatin 10 mg + Fenofibrate Tablets 160mg

Rosuvastatin 10 mg + Fenofibrate Tablets 160mg is a tablet formulated with Rosuvastatin 10 mg + Fenofibrate 160mg. The listed active ingredient profile is Rosuvastatin; Fenofibrate, placing the product in the lipid-lowering therapy category. The formulation contains lipid-lowering medicine(s) used to manage dyslipidaemia and cardiovascular risk where clinically appropriate. The source identifies the dosage form as tablet with not specified presentation. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.